Literature DB >> 26976144

Does the etiology of cardiac amyloidosis determine the myocardial uptake of [18F]-NaF PET/CT?

Christian Gagliardi1, Elena Tabacchi2, Rachele Bonfiglioli2, Stefania Diodato2, Cristina Nanni2, Pierluigi Guidalotti2, Massimiliano Lorenzini3, Filippo Lodi4, Agnese Milandri3, Claudio Rapezzi3, Stefano Fanti2.   

Abstract

Cardiac amyloidosis (CA) leads to variable degrees of myocardial infiltration with a final echocardiographic phenotype of "hypertrophy." Although many non-invasive imaging techniques (MRI, CT, scintigraphy, PET) are useful, the definitive diagnosis is still based on myocardial histology. We explored the possible role of [18F]-NaF PET/CT in the diagnosis of this disease in two cases with wild-type (ATTRwt) or mutant (ATTRm) Ile68Leu transthyretin (TTR)-related CA.

Entities:  

Keywords:  PET/CT imaging; [18F]-NaF PET/CT; cardiac amyloidosis; cardiomyopathy

Mesh：

Substances：

Year:  2016        PMID： 26976144     DOI： 10.1007/s12350-016-0457-8

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


  3 in total

1.  Usefulness and limitations of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy.

Authors:  Claudio Rapezzi; Candida Cristina Quarta; Pier Luigi Guidalotti; Simone Longhi; Cinzia Pettinato; Ornella Leone; Alessandra Ferlini; Fabrizio Salvi; Pamela Gallo; Christian Gagliardi; Angelo Branzi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-11-11       Impact factor: 9.236

2.  Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types.

Authors:  Claudio Rapezzi; Giampaolo Merlini; Candida C Quarta; Letizia Riva; Simone Longhi; Ornella Leone; Fabrizio Salvi; Paolo Ciliberti; Francesca Pastorelli; Elena Biagini; Fabio Coccolo; Robin M T Cooke; Letizia Bacchi-Reggiani; Diego Sangiorgi; Alessandra Ferlini; Michele Cavo; Elena Zamagni; Maria Luisa Fonte; Giovanni Palladini; Francesco Salinaro; Francesco Musca; Laura Obici; Angelo Branzi; Stefano Perlini
Journal:  Circulation       Date:  2009-09-14       Impact factor: 29.690

3.  [18F]-NaF PET/CT imaging in cardiac amyloidosis.

Authors:  Axel Van Der Gucht; Arnault Galat; Jean Rosso; Aziz Guellich; Jérôme Garot; Diane Bodez; Violaine Plante-Bordeneuve; Luc Hittinger; Jean-Luc Dubois-Randé; Eva Evangelista; Myriam Sasanelli; Julia Chalaye; Michel Meignan; Emmanuel Itti; Thibaud Damy
Journal:  J Nucl Cardiol       Date:  2015-09-24       Impact factor: 5.952
  3 in total
  12 in total

Review 1.  Role of Imaging in Evaluating Infiltrative Heart Disease.

Authors:  Sanjay Divakaran; Avinainder Singh; Bradley Collins; Tomas Vita; Rodney H Falk; Marcelo F Di Carli; Ron Blankstein
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-01

2.  Use of fluorine-18 sodium fluoride for the diagnosis of transthyretin cardiac amyloidosis: The birth of a new technique.

Authors:  Cesia Gallegos; Edward J Miller
Journal:  J Nucl Cardiol       Date:  2017-03-29       Impact factor: 5.952

Review 3.  Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis.

Authors:  Mathew S Maurer; Sabahat Bokhari; Thibaud Damy; Sharmila Dorbala; Brian M Drachman; Marianna Fontana; Martha Grogan; Arnt V Kristen; Isabelle Lousada; Jose Nativi-Nicolau; Candida Cristina Quarta; Claudio Rapezzi; Frederick L Ruberg; Ronald Witteles; Giampaolo Merlini
Journal:  Circ Heart Fail       Date:  2019-09-04       Impact factor: 8.790

Review 4.  Recent advances in the noninvasive strategies of cardiac amyloidosis.

Authors:  Lei Zhao; Quan Fang
Journal:  Heart Fail Rev       Date:  2016-11       Impact factor: 4.214

5.  18Fluorine sodium fluoride positron emission tomography, a potential biomarker of transthyretin cardiac amyloidosis.

Authors:  Rachelle Morgenstern; Randy Yeh; Adam Castano; Mathew S Maurer; Sabahat Bokhari
Journal:  J Nucl Cardiol       Date:  2017-02-07       Impact factor: 5.952

6.  Transthyretin Cardiac Amyloidosis in Older Adults: Optimizing Cardiac Imaging to the Corresponding Diagnostic and Management Goal.

Authors:  Adam Castaño; Daniel K Manson; Mathew S Maurer; Sabahat Bokhari
Journal:  Curr Cardiovasc Risk Rep       Date:  2017-04-25

7.  Update of the Brazilian Guideline on Nuclear Cardiology - 2020.

Authors:  Luiz Eduardo Mastrocola; Barbara Juarez Amorim; João Vicente Vitola; Simone Cristina Soares Brandão; Gabriel Blacher Grossman; Ronaldo de Souza Leão Lima; Rafael Willain Lopes; William Azem Chalela; Lara Cristiane Terra Ferreira Carreira; José Roberto Nolasco de Araújo; Cláudio Tinoco Mesquita; José Claudio Meneghetti
Journal:  Arq Bras Cardiol       Date:  2020-02       Impact factor: 2.000

8.  18F-Sodium Fluoride PET/MR for the Assessment of Cardiac Amyloidosis.

Authors:  Maria Giovanna Trivieri; Marc R Dweck; Ronan Abgral; Philip M Robson; Nicolas A Karakatsanis; Anuradha Lala; Johanna Contreras; Gagan Sahni; Radha Gopalan; Peter Gorevic; Valentin Fuster; Jagat Narula; Zahi A Fayad
Journal:  J Am Coll Cardiol       Date:  2016-12-20       Impact factor: 24.094

Review 9.  Novel Noninvasive Nuclear Medicine Imaging Techniques for Cardiac Inflammation.

Authors:  Malte Kircher; Constantin Lapa
Journal:  Curr Cardiovasc Imaging Rep       Date:  2017-02-10

Review 10.  Multimodality Imaging in the Evaluation and Management of Cardiac Amyloidosis.

Authors:  Yiu Ming Khor; Sarah Cuddy; Rodney H Falk; Sharmila Dorbala
Journal:  Semin Nucl Med       Date:  2020-02-09       Impact factor: 4.802
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.